Phanesthera
1 known investors
Phanes Therapeutics is a clinical-stage biotech company developing bispecific antibodies and other biologics for immuno-oncology, with three Phase 2 trials (spevatamig, peluntamig, mavrostobart). It uses proprietary platforms — PACbody, SPECpair, and ATACCbody — to build cancer therapeutics addressing unmet medical needs.
Investors · 1
Frequently asked questions
- What does Phanesthera do?
- Phanes Therapeutics is a clinical-stage biotech company developing bispecific antibodies and other biologics for immuno-oncology, with three Phase 2 trials (spevatamig, peluntamig, mavrostobart). It uses proprietary platforms — PACbody, SPECpair, and ATACCbody — to build cancer therapeutics addressing unmet medical needs.
- Who are Phanesthera's investors?
- Phanesthera's investors include Delos Capital.